
Biotechnology • Science • B2B
Molecular Matrix, Inc. is a biotechnology company developing next-generation osteobiologic therapeutics and biomaterials for bone repair and regeneration. Founded in 2011 and led by Charles Lee, Ph. D. , the company’s Osteopoietic Systems® platform includes Osteo-P® BGS, a hyper-crosslinked carbohydrate polymer bone graft substitute that received FDA 510(k) clearance in 2017. Molecular Matrix focuses on synthetic, biocompatible, high-porosity implants and therapies for orthopedic, spine, and trauma care that are designed to accelerate healing, match bone formation profiles, and improve patient outcomes.
November 5
Biologics Territory Manager responsible for sales growth and customer engagement in the medical device industry. Collaborate with health partners and maintain territory revenue goals.